NEW ASSOCIATION BETWEEN 4-{3-[CIS-HEXAHYDROCYCLOPENTA[C]PYRROL-2 (1H) -YL]PROPOXY??BENZAMIDE AND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
The present invention is a pharmaceutical, a derivative of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of chemical formula (I) or an additional salt with a pharmaceutically active acid or base, and an acetylcholinesterase inhibitor. [Reference numerals] (AA) Test procedure； (BB) Tronche et al. changed after 2010； (CC) Food； (DD) No food； (EE) Contextual； (FF) Serial distinguishment test； (GG) Two different contexts of two continuous distinguishment； (HH,SS) Treatment； (II,TT) Room C； (JJ,UU) Injection of a compound or glycone； (KK) Learn； (LL,OO,WW) Room A； (MM,PP) hole with a bait； (NN) Room B； (QQ) Retention time； (RR) Animal quarters； (VV) Test； (XX) Correct response； (YY) Mistake； (ZZ) Interference response본 발명은 하기 화학식(I)의 4-{3-[시스-헥사하이드로시클로펜타[c]피롤-2(1H)-일]프로폭시}벤즈아미드 또는 약제학적으로 허용되는 산 또는 염기와의 이의 부가염과 아세틸콜린에스테라제 억제제의 회합체 및 의약에 관한 것이다:
